These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 6203382)

  • 1. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
    Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
    Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside].
    Kinoshita N; Tochigi H; Yanagawa M; Yamakawa K; Sakurai M; Hioki T; Kawamura J
    Hinyokika Kiyo; 1990 Mar; 36(3):257-63. PubMed ID: 1693807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin].
    Kumamoto Y; Tsukamoto T; Tamiya T; Takatsuka K; Furuya S; Yokoyama E; Honma A; Aoyama T; Tanda H; Kato S
    Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Instillation chemotherapy with peplomycin in superficial bladder cancer: clinical study on the effects of the direct antitumor activity and of the prophylaxis of recurrence].
    Sonoda T; Osafune M; Matsuda M; Usami M
    Hinyokika Kiyo; 1988 Mar; 34(3):574-81. PubMed ID: 2455442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental and clinical studies on intravesical instillation therapy for bladder cancer].
    Yamanaka H; Kaburagi Y; Imai K; Miki M
    Hinyokika Kiyo; 1983 Nov; 29(11):1427-32. PubMed ID: 6428193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intra-arterial infusion chemotherapy for superficial bladder cancer].
    Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
    Hinyokika Kiyo; 1999 Sep; 45(9):605-7. PubMed ID: 10540704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH; Bai JL; Zhang SS; Ma PC; Wan JH
    Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our experience with combined intravesical instillation therapy of superficial bladder tumor using Aclacinomycin-A (ACM) and cytosine arabinoside (CA)].
    Tsugaya M; Iwase Y; Sakagami H; Washida H
    Hinyokika Kiyo; 1987 Aug; 33(8):1180-4. PubMed ID: 3480687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K; Chihara Y; Kondo H; Hirao Y
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis of recurrence of superficial bladder tumor by intravesical chemotherapy].
    Ikeda R; Kawamura K; Yamaguchi C; Miyazawa K; Sasagawa M; Taniguchi T; Shiraiwa K; Suzuki K; Tsugawa T; Kudo T
    Hinyokika Kiyo; 1989 Jul; 35(7):1135-9. PubMed ID: 2478008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
    Masuda F; Mori Y; Torii S; Kawashima Y; Kobari T; Hosobe T
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):505-8. PubMed ID: 1558400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy].
    Ikeuchi T; Onodera Y; Kai Y
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):858-63. PubMed ID: 6426397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical instillation chemotherapy of anticancer agents including cylocide: studies of prophylactic effects on the recurrence].
    Yasumoto R; Asakawa M; Yoshihara H; Sakamoto W; Iseki T; Nakatani T; Wada S; Kishimoto T; Maekawa M; Nishio S
    Hinyokika Kiyo; 1990 Apr; 36(4):407-13. PubMed ID: 2116082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence].
    Hashimoto H; Yachiku S; Watabe Y; Niibori D; Yamauchi K; Osanai H; Ohashi K; Wakabayashi A; Fujisawa M
    Gan To Kagaku Ryoho; 1994 May; 21(6):833-8. PubMed ID: 8185341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
    Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H
    Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.